相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2
Beatriz Perez-Benavente et al.
GENOME BIOLOGY (2022)
Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4
Soledad A. Camolotto et al.
GUT (2021)
Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis
Hua Su et al.
CANCER CELL (2021)
Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancer
Nawab Azizi et al.
ONCOGENE (2021)
Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein
Tianyu Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
CCL28 Downregulation Attenuates Pancreatic Cancer Progression Through Tumor Cell-Intrinsic and -Extrinsic Mechanisms
Jingjing Yan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer
Mengyu Tu et al.
NATURE CANCER (2021)
FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts
Xueying Wan et al.
THERANOSTICS (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth
Ja Hyun Koo et al.
GENES & DEVELOPMENT (2020)
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Louis Buscail et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Targeting the MAPK Pathway in KRAS-Driven Tumors
Matthias Drosten et al.
CANCER CELL (2020)
Blockade of β-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration
Lu Ji et al.
CANCER RESEARCH (2020)
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Luisa F. Escobar-Hoyos et al.
CANCER CELL (2020)
Efficient low-cost chromatin profiling with CUT&Tag
Hatice S. Kaya-Okur et al.
NATURE PROTOCOLS (2020)
Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis
Liping Han et al.
BMC PULMONARY MEDICINE (2020)
EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy
Shuli Liu et al.
THERANOSTICS (2020)
Challenges in Ras therapeutics in pancreatic cancer
Minsig Choi et al.
SEMINARS IN CANCER BIOLOGY (2019)
Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma
Junya Peng et al.
CELL RESEARCH (2019)
CUT&Tag for efficient epigenomic profiling of small samples and single cells
Hatice S. Kaya-Okur et al.
NATURE COMMUNICATIONS (2019)
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer
Vasileios Atsaves et al.
CANCERS (2019)
MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2)
Shuo Li et al.
FRONTIERS IN ONCOLOGY (2019)
HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer
Jun Yin et al.
ONCOTARGETS AND THERAPY (2019)
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Akram Pourshams et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Menin Coordinates C/EBPβ-Mediated TGF-β Signaling for Epithelial-Mesenchymal Transition and Growth Inhibition in Pancreatic Cancer
Peng Cheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
FOSL1 Promotes Kras-induced Lung Cancer through Amphiregulin and Cell Survival Gene Regulation
Indira M. Elangovan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-beta/Smad3 signaling pathway
Lu Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Elisabeth Hessmann et al.
GUT (2017)
CCL28 chemokine: An anchoring point bridging innate and adaptive immunity
Teena Mohan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
Oliver G. McDonald et al.
NATURE GENETICS (2017)
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
M. Ryan Corces et al.
NATURE METHODS (2017)
Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis
Jae-Seok Roe et al.
CELL (2017)
Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice
Chiharu Moriya et al.
CARCINOGENESIS (2017)
ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
Guangchuang Yu et al.
BIOINFORMATICS (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Susann Weissmueller et al.
CELL (2014)
deepTools: a flexible platform for exploring deep-sequencing data
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2014)
FOSL2 Positively Regulates TGF-β1 Signalling in Non-Small Cell Lung Cancer
Junfeng Wang et al.
PLOS ONE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Microenvironmental Regulation of BRCA1 Gene Expression by c-Jun and Fra2 in Premalignant Human Ovarian Surface Epithelial Cells
Lixin Zhou et al.
MOLECULAR CANCER RESEARCH (2013)
Target analysis by integration of transcriptome and ChIP-seq data with BETA
Su Wang et al.
NATURE PROTOCOLS (2013)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
CCR10 and its ligands in regulation of epithelial immunity and diseases
Na Xiong et al.
PROTEIN & CELL (2012)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
BigWig and BigBed: enabling browsing of large distributed datasets
W. J. Kent et al.
BIOINFORMATICS (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia
Fatih M. Uckun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
OPINION Emerging roles of ATF2 and the dynamic AP1 network in cancer
Pablo Lopez-Bergami et al.
NATURE REVIEWS CANCER (2010)
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2α overexpression
N. Jonckheere et al.
BRITISH JOURNAL OF CANCER (2009)
Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma
Minoru Kitago et al.
CLINICAL CANCER RESEARCH (2009)
The coactivator CRTC1 promotes cell proliferation and transformation via AP-1
Gianluca Canettieri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Tumor vascular proteins as biomarkers in ovarian cancer
Ronald J. Buckanovich et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites
SK Lau et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas
GE Kim et al.
GASTROENTEROLOGY (2002)
AP-1 as a regulator of cell life and death
E Shaulian et al.
NATURE CELL BIOLOGY (2002)
Cutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues
JL Pan et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
